Last reviewed · How we verify

NCT03148977

Evaluating MMPs in Burns

Terminated Last updated 26 March 2021
What this trial tests

trial testing Graft in Burns in 8 participants. Terminated before completion.

Timeline
9 June 2017
Primary endpoint
8 December 2020
8 December 2020

Quick facts

Lead sponsorUniversity of Florida
StatusTerminated
Study typeOBSERVATIONAL
Enrollment8
Start date9 June 2017
Primary completion8 December 2020
Estimated completion8 December 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 18 to 98, any sex, with Burns or Thermal Burn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine whether our chemical assay can be used to reliably predict graft take or failure in patients undergoing autologous skin grafting for treatment of acute burn injury.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advanced Wound Diagnostics: Toward Transforming Wound Care into Precision Medicine.
    Weigelt MA, Lev-Tov HA, Tomic-Canic M, Lee WD, et al · · 2022 · cited 45× · PMID 34128387 · DOI 10.1089/wound.2020.1319

Verify or expand the search:

Other recruiting trials for Burns

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03148977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing